Colonization, fomites, and virulence: Rethinking the pathogenesis of community-associated methicillin-resistant staphylococcus aureus infection

Clinical Infectious Diseases

Volumn 46, Issue 5, 2008, Pages 752-760

  Miller, Loren G ^a,b   Diep, Binh An ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC;

BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; ENVIRONMENTAL FACTOR; EPIDEMIC; FOMITE; HOST RESISTANCE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS INFECTION; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; DRUG EFFECT; MICROBIOLOGY; PENICILLIN RESISTANCE; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS; VIRULENCE;

COMMUNITY-ACQUIRED INFECTIONS; FOMITES; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 39749168427     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/526773     Document Type: Review

References (96)

1. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2005; 41(Suppl 4):S269-72.
2. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Recomm Rep 1999; 48:707-10. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4832a2.htm.
3. Fergie JE, Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J 2001; 20:860-3.
4. Faden H, Ferguson S. Community-acquired methicillin-resistant Staphylococcus aureus and intrafamily spread of pustular disease. Pediatr Infect Dis J 2001; 20:554-5.
5. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities - Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003; 52:992-6.
6. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52:793-5.
7. Begier EM, Frenette K, Barrett NL, et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 2004; 39:1446-53.
8. Zinderman CE, Conner B, Malakooti MA, LaMar JE, Armstrong A, Bohnker BK. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004; 10:941-4.
9. Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52:88.
10. Lee NE, Taylor MM, Bancroft E, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005; 40:1529-34.
11. Miller LG, Tagudar G, Tsui J, et al. A prospective investigation of risk factors for community-acquired MRSA infection in a non-outbreak setting [abstract LB-7; oral abstract, late breaker]. In: Program and abstracts of the 42nd Annual Meeting of the Infectious Disease Society of America (Boston). Alexandria, VA: Infectious Diseases Society of America, 2004.
12. Laibl VR, Sheffield JS, Roberts S, McIntire DD, Trevino S, Wendel GD Jr. Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy. Obstet Gynecol 2005; 106:461-5.
13. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005; 11:928-30.
14. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003; 16:103-24.
15. Wu KC, Chiu HH, Wang JH, et al. Characteristics of community-acquired methicillin-resistant Staphylococcus aureus in infants and children without known risk factors. J Microbiol Immunol Infect 2002; 35:53-6.
16. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001; 33:990-6.
17. Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40:100-7.
18. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-53.
19. Mongkolrattanothai K, Boyle S, Kahana MD, Daum RS. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 2003; 37:1050-8.
20. Crum NF, Lee RU, Thornton SA, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006; 119:943-51.
21. Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 2005; 24:457-8.
22. Miller LG, Quan C, Shay A, et al. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis 2007; 44:483-92.
23. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA; Participants in the CDC-Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Available at: http://cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA_ExpMtgStrategies.pdf. Accessed 22 May 2006.
24. Federal Bureau of Prisons-Clinical Practice Guidelines. Management of methicillin-resistant Staphylococcus aureus (MRSA) infections. August 2005. Available at: http://www.bop.gov/news/PDFs/mrsa.pdf. Accessed 22 August 2005.
25. Washington State Department of Health. Interim guidelines for evaluation & management of community associated methicillin resistant Staphylococcus aureus skin and soft tissue infections in outpatient setting. Available at: http://www.doh.wa.gov/topics/Antibiotics/MRSAInterim.htm. Accessed 27 June 2005.
26. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993; 94:313-28.
27. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-20.
28. Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991; 114:101-6.
29. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344:11-6.
30. Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364:703-5.
31. Doebbeling BN, Reagan DR, Pfaller MA, Houston AK, Hollis RJ, Wenzel RP. Long-term efficacy of intranasal mupirocin ointment: a prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994; 154:1505-8.
32. Loeb M, Main C, Walker-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003:CD003340.
33. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin- resistant Staphylococcus aureus among professional football players. N Engl J Med 2005; 352:468-75.
34. Baggett HC, Hennessy TW, Rudolph K, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004; 189:1565-73.
35. Mathews WC, Caperna J, Barber E, et al. Incidence of and risk factors for clinically significant MRSA infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005; 40:155-60.
36. Wener K, Gold H, Wong M, et al. High prevalence of methicillin-resistant Staphylococcus aureus (MRSA) colonization in an urban outpatient population [abstract 380]. In: Program and abstracts of the 44th Annual Meeting of the Infectious Disease Society of America (Toronto). Alexandria, VA: Infectious Diseases Society of America, 2006:118.
37. Ly LT, Revuelta MP, Hongo I, Kreiswirth BN, Davis S, Saltzman BR. Clonal outbreak of community-acquired methicillin resistant Staphylococcus aureus skin abscesses in men who have sex with men in New York City: possible association with crystal methamphetamine usage [abstract No. 490]. In: Programs and abstracts of the 42nd Annual Meeting of the Infectious Diseases Society of America (Boston). Alexandria, VA: Infectious Diseases Society of America, 2004:133.
38. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008; 148:249-57.
39. Cook HA, Furuya EY, Larson E, Vasquez G, Lowy FD. Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2007; 44:410-3.
40. Rieg G, Daar E, Witt M, Guerrero M, Miller L. Community-acquired methicillin resistant Staphylococcus aureus colonization among HIV-infected men who have sex with men: a point prevalence survey [abstract 877]. In: Program and abstracts of the 12th Conference on Retroviruses and Opportunistic Infections (Boston). Alexandria, VA: Foundation for Retrovirology and Human Health, 2005.
41. Yang ES, Tan J, Rieg G, Miller LG. Body site colonization prevalence in patients with community-associated methicillin-resistant Staphylococcus aureus infections [abstract 285]. In: Program and abstracts of the 45th Annual Meeting of the Infectious Disease Society of America (San Diego). Alexandria, VA: Infectious Diseases Society of America, 2007:107.
42. Nguyen DM, Mascola L, Brancoft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 2005; 11:526-32.
43. Miller LG, Matayoshi K, Spellberg B, et al. A prospective investigation of community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) risk factors in infected and non-infected patients [abstract 1058]. In: Program and abstracts of the 43rd Annual Meeting of the Infectious Disease Society of America (San Francisco). Alexandria, VA: Infectious Diseases Society of America, 2005:233.
44. Ojima M, Toshima Y, Koya E, et al. Hygiene measures considering actual distributions of microorganisms in Japanese households. J Appl Microbiol 2002; 93:800-9.
45. Smith MA, Mathewson JJ, Ulert IA, Scerpella EG, Ericsson CD. Contaminated stethoscopes revisited. Arch Intern Med 1996; 156:82-4.
46. Singh D, Kaur H, Gardner WG, Treen LB. Bacterial contamination of hospital pagers. Infect Control Hosp Epidemiol 2002; 23:274-6.
47. Hardy KJ, Oppenheim BA, Gossain S, Gao F, Hawkey PM. A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients' acquisition of MRSA. Infect Control Hosp Epidemiol 2006; 27:127-32.
48. Vriens M, Blok H, Fluit A, Troelstra A, Van Der Werken C, Verhoef J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis 2002; 21:782-6.
49. Meek C. Isolate patients, screen staff to fight MRSA. CMAJ 2004; 171:1158.
50. Ragan P. Community-acquired MRSA infection: an update. Jaapa 2006; 19:24-9.
51. Minnesota Department of Health. Community-associated methicillin- resistant Staphylococcus aureus in Minnesota. Minnesota Department of Health Disease Control Newsletter 2004; 32:61-72.
52. Coronado F, Nicholas JA, Wallace BJ, et al. Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community. Epidemiol Infect 2006; 135:492-501.
53. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
54. Pan ES, Diep BA, Carleton HA, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 2003; 37:1384-8.
55. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison - Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:919-22.
56. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin infections among tattoo recipients - Ohio, Kentucky, and Vermont, 2004-2005. MMWR Morb Mortal Wkly Rep 2006; 55:677-9.
57. Stemper ME, Brady JM, Qutaishat SS, et al. Shift in Staphylococcus aureus clone linked to an infected tattoo. Emerg Infect Dis 2006; 12:1444-6.
58. Hulten KG, Kaplan SL, Gonzalez BE, et al. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J 2006; 25:349-53.
59. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115:642-8.
60. Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO Jr, Kaplan SL. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006; 43:953-60.
61. Buckingham SC, McDougal LK, Cathey LD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J 2004; 23:619-24.
62. Gonzalez BE, Teruya J, Mahoney DH Jr, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 2006; 117:1673-9.
63. Nguyen DM, Bancroft E, Mascola L, Guevara R, Yasuda L. Risk factors for neonatal methicillin-resistant Staphylococcus aureus infection in a well-infant nursery. Infect Control Hosp Epidemiol 2007; 28:406-11.
64. Huang H, Flynn NM, King JH, Monchaud C, Morita M, Cohen SH. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol 2006; 44:2423-7.
65. Haque NZ, Davis SL, Manierski CL, et al. Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2007; 30:72-7.
66. Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007; 51:423-8.
67. Campbell KM, Vaughn AF, Russell KL, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol 2004; 42:4050-3.
68. Beilman GJ, Sandifer G, Skarda D, et al. Emerging infections with community-associated methicillin-resistant Staphylococcus aureus in outpatients at an Army Community Hospital. Surg Infect (Larchmt) 2005; 6:87-92.
69. Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau-Remington F. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 2004; 42:2080-4.
70. Estivariz CF, Park SY, Hageman JC, et al. Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003. J Infect 2007; 54:349-57.
71. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007; 44:471-82.
72. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40:1785-91.
73. Pan ES, Diep BA, Charlebois ED, et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus - and their relation to community-associated disease activity. J Infect Dis 2005; 192:811-8.
74. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 2006; 193:1495-503.
75. Adam H, McGeer A, Simor A. Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Can Commun Dis Rep 2007; 33:45-8.
76. Larsen A, Stegger M, Goering R, Sorum M, Skov R. Emergence and dissemination of the methicillin resistant Staphylococcus aureus USA300 clone in Denmark (2000-2005). Euro Surveill 2007; 12.
77. Kearns AM, Ganner M, Hill RLR, et al. Community-associated MRSA ST8-SCCmecIVa (USA-300): experience in England and Wales. Oral presentation at the 17th European Congress of Clinical Microbiology and Infectious Diseases, Munich, Germany, 31 March-3 April 2007. Clin Microbiol Infect 2007; 13:S27.
78. Tinelli M, Pantosti A, Lusardi C, Vimercati M, Monaco M. First detected case of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infection in Italy. Euro Surveill 2007; 12: E070412.1. Available at: http://www.eurosurveillance.org/ew/2007/070412.asp#1. Accessed 8 January 2008.
79. Wannet W, Heck M, Pluister G, et al. Panton-Valentine leukocidin positive MRSA in 2003 : the Dutch situation. Euro Surveill 2004; 9:28-9.
80. Larsen A, Stegger M, Goering R, Sorum M, Skov R. Emergence and dissemination of the methicillin-resistant Staphylococcus aureus USA300 clone in Denmark (2000-2005). Euro Surveill 2007; 12.
81. Ruppitsch W, Stoger A, Schmid D, et al. Occurrence of the USA300 community-acquired Staphylococcus aureus clone in Austria. Euro Surveill 2007; 12:E071025.1.
82. Gilbert M, MacDonald J, Gregson D, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 2006; 175:149-54.
83. Chambers HF. Community-associated MRSA - resistance and virulence converge. N Engl J Med 2005; 352:1485-7.
84. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194:1761-70.
85. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315:1130-3.
86. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Update 2003; 6:41-52.
87. Ender M, McCallum N, Adhikari R, Berger-Bachi B. Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus. Antimicrob Agents Chemother 2004; 48:2295-7.
88. Lee SM, Ender M, Adhikari R, Smith JM, Berger-Bachi B, Cook GM. Fitness cost of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus by way of continuous culture. Antimicrob Agents Chemother 2007; 51:1497-9.
89. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 2006; 367:731-9.
90. Diep BA, Stone GG, Basuino L, et al. The ACME and SCCmec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis (in press).
91. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004; 190:1730-8.
92. Burlak C, Hammer CH, Robinson MA, et al. Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell Microbiol 2007; 9:1172-90.
93. Dinauer MC. Chronic granulomatous disease and other disorders of phagocyte function. Hematology Am Soc Hematol Educ Program 2005: 89-95.
94. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-60.
95. Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39:47-54.
96. Nolan JL. A flexible approach to methicillin-resistant Staphylococcus aureus (MRSA). Nurs Times 2001; 97:57-8.